These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64 related articles for article (PubMed ID: 15888830)
21. Montelukast added to inhaled beclomethasone in treatment of asthma. Montelukast/Beclomethasone Additivity Group. Laviolette M; Malmstrom K; Lu S; Chervinsky P; Pujet JC; Peszek I; Zhang J; Reiss TF Am J Respir Crit Care Med; 1999 Dec; 160(6):1862-8. PubMed ID: 10588598 [TBL] [Abstract][Full Text] [Related]
22. Effect of the addition of montelukast to inhaled fluticasone propionate on airway inflammation. O'Sullivan S; Akveld M; Burke CM; Poulter LW Am J Respir Crit Care Med; 2003 Mar; 167(5):745-50. PubMed ID: 12480610 [TBL] [Abstract][Full Text] [Related]
23. Effect of fluticasone/salmeterol administered via a single device on exercise-induced bronchospasm in patients with persistent asthma. Weiler JM; Nathan RA; Rupp NT; Kalberg CJ; Emmett A; Dorinsky PM Ann Allergy Asthma Immunol; 2005 Jan; 94(1):65-72. PubMed ID: 15702819 [TBL] [Abstract][Full Text] [Related]
25. Add-on montelukast vs double-dose budesonide in nonasthmatic eosinophilic bronchitis: a pilot study. Cai C; He MZ; Zhong SQ; Tang Y; Sun BQ; Chen QL; Zhong NS Respir Med; 2012 Oct; 106(10):1369-75. PubMed ID: 22819521 [TBL] [Abstract][Full Text] [Related]
26. Montelukast attenuates the airway response to hypertonic saline in moderate-to-severe COPD. Zühlke IE; Kanniess F; Richter K; Nielsen-Gode D; Böhme S; Jörres RA; Magnussen H Eur Respir J; 2003 Dec; 22(6):926-30. PubMed ID: 14680080 [TBL] [Abstract][Full Text] [Related]
27. Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukast. Nelson HS; Busse WW; Kerwin E; Church N; Emmett A; Rickard K; Knobil K J Allergy Clin Immunol; 2000 Dec; 106(6):1088-95. PubMed ID: 11112891 [TBL] [Abstract][Full Text] [Related]
28. A randomized open-label comparative study of montelukast versus theophylline added to inhaled corticosteroid in asthmatic children. Kondo N; Katsunuma T; Odajima Y; Morikawa A Allergol Int; 2006 Sep; 55(3):287-93. PubMed ID: 17075269 [TBL] [Abstract][Full Text] [Related]
29. Effects of montelukast on airway narrowing from eucapnic voluntary hyperventilation and cold air exercise. Rundell KW; Spiering BA; Baumann JM; Evans TM Br J Sports Med; 2005 Apr; 39(4):232-6. PubMed ID: 15793094 [TBL] [Abstract][Full Text] [Related]
30. Montelukast, compared with fluticasone, for control of asthma among 6- to 14-year-old patients with mild asthma: the MOSAIC study. Garcia Garcia ML; Wahn U; Gilles L; Swern A; Tozzi CA; Polos P Pediatrics; 2005 Aug; 116(2):360-9. PubMed ID: 16061590 [TBL] [Abstract][Full Text] [Related]
31. Single-dose desloratadine and montelukast and allergen-induced late airway responses. Davis BE; Illamperuma C; Gauvreau GM; Watson RM; O'Byrne PM; Deschesnes F; Boulet LP; Cockcroft DW Eur Respir J; 2009 Jun; 33(6):1302-8. PubMed ID: 19164343 [TBL] [Abstract][Full Text] [Related]
32. Effect of combined montelukast and desloratadine on the early asthmatic response to inhaled allergen. Davis BE; Todd DC; Cockcroft DW J Allergy Clin Immunol; 2005 Oct; 116(4):768-72. PubMed ID: 16210049 [TBL] [Abstract][Full Text] [Related]
33. Salmeterol response is not affected by beta2-adrenergic receptor genotype in subjects with persistent asthma. Bleecker ER; Yancey SW; Baitinger LA; Edwards LD; Klotsman M; Anderson WH; Dorinsky PM J Allergy Clin Immunol; 2006 Oct; 118(4):809-16. PubMed ID: 17030231 [TBL] [Abstract][Full Text] [Related]
34. Oral montelukast treatment of preschool-aged children with acute asthma. Harmanci K; Bakirtas A; Turktas I; Degim T Ann Allergy Asthma Immunol; 2006 May; 96(5):731-5. PubMed ID: 16729788 [TBL] [Abstract][Full Text] [Related]
35. Prolonged effect of montelukast in asthmatic children with exercise-induced bronchoconstriction. Kim JH; Lee SY; Kim HB; Kim BS; Shim JY; Hong TJ; Hong SJ Pediatr Pulmonol; 2005 Feb; 39(2):162-6. PubMed ID: 15633203 [TBL] [Abstract][Full Text] [Related]
36. Effects of montelukast on surrogate inflammatory markers in corticosteroid-treated patients with asthma. Currie GP; Lee DK; Haggart K; Bates CE; Lipworth BJ Am J Respir Crit Care Med; 2003 May; 167(9):1232-8. PubMed ID: 12456382 [TBL] [Abstract][Full Text] [Related]
37. Fast onset of effect of budesonide/formoterol versus salmeterol/fluticasone and salbutamol in patients with chronic obstructive pulmonary disease and reversible airway obstruction. Lindberg A; Szalai Z; Pullerits T; Radeczky E Respirology; 2007 Sep; 12(5):732-9. PubMed ID: 17875063 [TBL] [Abstract][Full Text] [Related]
38. [Adding an anti-leukotriene: results of the IMPACT study]. Lipworth B Rev Pneumol Clin; 2003 Sep; 59(4):261-7. PubMed ID: 14705613 [No Abstract] [Full Text] [Related]
39. Fluticasone propionate/salmeterol combination compared with montelukast for the treatment of persistent asthma. Pearlman DS; White MV; Lieberman AK; Pepsin PJ; Kalberg C; Emmett A; Bowers B; Rickard KA; Dorinsky P Ann Allergy Asthma Immunol; 2002 Feb; 88(2):227-35. PubMed ID: 11868930 [TBL] [Abstract][Full Text] [Related]
40. When an asthma drug has an inferiority complex: a noninferiority trial. Goodman DC Pediatrics; 2005 Aug; 116(2):493-5. PubMed ID: 16061609 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]